-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Elicio Therapeutics, Raises Price Target to $13

Benzinga·07/17/2025 10:34:51
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Elicio Therapeutics (NASDAQ:ELTX) with a Buy and raises the price target from $10 to $13.